Background. The potential benefits of high-field magnetic resonance (MR) include increased signal, contrast, and spectral/spatial resolution, however there are specific safety and cost implications.
PROTEIN C CONCENTRATE FOR SEPSIS-INDUCED COAGULOPATHY IN NEWBORN

NICU AND PEDIATRIC INTENSIVE CARE UNIT UNIVERSITY OF FERRARA (ITALY)
Sepsis results in pronounced hypercoagulability due to the strong activation of coagulation, depletion of anticoagulant factors and impairment of normal fibrynolitic response. Protein C (PC) is a natural anticoagulant and also has important anti-inflammatory activity. We reports the effects of substitution with a human, virus-inactivated protein C concentrate (Ceprotin) in neonatal sepsis. Design:case series. Setting: open-label, non randomized study conducted in 6 neonatal care units. Objectives: to perform a preliminary analysis of the clinical and laboratory effects of PC concentrate as an adjunt to conventional therapy in the treatment of sepsis-induced coagulopathy. Patients: 11 neonates with a median gestational age of 31 week (range: 26 to 40W) 4F/7M, median birth weight of 1034 g (range: 586 to 3350) received an initial intravenous bolus of 100 IU/kg followed by 50 IU/kg six time per day. All patients presented with low plasma PC acitivity prior treatment (median: 18,1%, range 10% to 25%). Results: a rise in plasma PC activity levels to within normal limits at 48h (Pϭ0,01) and manteinment until 72h. Improving or even partial correction of hemostasis, and normalization of infectious parameters were assessed in all patients. No adverse effects were observed. One patient died. Discussions and conclusions: the administration of PC concentrate had a marked benefit on the deranged coagulation status of patients and revealed safe leading to a resolution of coagulation imbalance. These encouraging clinical and laboratory results and the absence of side effects warrant the initiation of a double blind randomized controlled multicenter trial. (Table) . The product/substrate ratios for the delta-6-desaturase enzyme ([GLAϩDHGLA]/LA) were significantly and positively related to RBW and to the waist/hip ratio (Table) . 
ANTHROPOMETRIC INDICES INDICATIVE OF OBESITY ARE POSITIVELY RELATED TO N-6 LONG-CHAIN POLYUNSATURATED FATTY ACIDS IN PLASMA LIPIDS OF OBESE CHILDREN
Conclusions:
1. In the present study, various anthropometric indices indicative of obesity were significantly and positively related to n-6 long-chain polyunsaturated fatty acids in plasma lipids of obese children. 2. The product/substrates ratios for the delta-6 desaturase enzyme indicated enhanced conversion rate with more pronounced obesity. 3. Extent of obesity should be taken into account in studies on fatty acid metabolism in obese subjects. 
PROLONGED SEDATION / ANALGESIA ( S/A ) AND 4-YEAR OUTCOME IN PRETERM NEWBORNS : RESULTS FROM THE EPIPAGE COHORT.
CENTRE NATIONAL DE RESSOURCES DE LUTTE CONTRE LA DOULEUR, HOPITAL D'ENFANT ARMAND TROUSSEAU (FRANCE)
Background: It seems adequate to relieve pain in newborns and necessary to evaluate the benefit/risk ratio of this therapy.Is there a relationship between prolonged S/A and long-term outcome of extremely preterm infants?
Objective: Evaluation of association between prolonged S/A and 4-year outcome of preterms in EPIPAGE cohort.
Method: Based on a propensity score, preterms were divided in 2 groups according to the probability of needing prolonged S/A :low ( Ͻ 20 % ) or high probability ( Ͼ/ϭ20 % ).Dependent variable was S/A. Independent variables were CRIB score, prematurity, ventilation, surgery and postnatal corticotherapy. 4-year outcome was classified as: death, alive at 4 years with or without difficulties (cerebral palsy, developmental problem considered by parents or difficulties at school).
Results: Information on S/A was recorded in 2441 newborns alive at discharge. Without taking account propensity score, 35.5 % and 75.5 % of preterms with or without prolonged S/A respectively had no difficulties at 4-year follow-up.
Conclusion:
Prolonged S/A is associated with a poor 4-year outcome in preterm newborns.But this may be explained by the severity of the illness.
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